Recently, our group has investigated the role of CD40-CD40L-TRAF6 signaling in patients suffering from coronary heart disease and accompanied by arterial hypertension and/or diabetes and found comparable pathways in respective mouse models [11]. This evidence concerns the gene CD40LG and diabetes mellitus.